This suggests that in NAFLD, hyperinsulinemia, and hepatic insulin resistance result from decreased hepatic IRS1 expression associated with hepatic necroinflammatory activity. This evidence concerns the gene IRS1 and metabolic dysfunction-associated steatotic liver disease.